The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...

Yet despite decades of research, no treatment has been created that arrests Alzheimer’s cognitive deterioration, let alone ...

The findings of the study suggest that regularly engaging in this type of exercise could significantly reduce the number of ...

We now have two FDA-approved disease-modifying treatments for Alzheimer's disease, and hundreds of clinical trials are ...

LATE is a prevalent condition in late life and can contribute to memory loss and cognitive decline, according to report ...

Late-onset Alzheimer's disease is a debilitating, progressive neurodegenerative disease that affects about 7 million ...

The geroscience hypothesis focuses on extending the healthy lifespan by targeting aging mechanisms. Recent advances in ...

Anti-inflammatory drugs like ibuprofen, along with antibiotics, antiviral medications, and vaccines are associated with a ...

Researchers uncover promising evidence that xenon gas, commonly used in anesthesia, may help reduce brain deterioration and ...

New drug approvals and a federal dementia care pilot program among the year's significant developments, according to the ...

Understanding dementia and Alzheimer’s disease is essential for maintaining a proactive approach to our well-being.

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...